Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Intravenous and oral administration of amiodarone for the management of recent onset atrial fibrillation (AF): a randomized, digoxin and disopyramide controlled trial
ISRCTN ISRCTN87656977
ClinicalTrials.gov identifier
Public title Intravenous and oral administration of amiodarone for the management of recent onset atrial fibrillation (AF): a randomized, digoxin and disopyramide controlled trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis To confirm if oral amiodarone is as effective as intravenous amiodarone in restoring sinus rhythm in patients with recent AF.
Lay summary
Ethics approval Provided by the Ethics Committee of the Medical School of the University of Athens on 12/03/1999.
Study design Randomized controlled trial
Countries of recruitment Greece
Disease/condition/study domain Atrial fibrillation
Participants - inclusion criteria Patients with recent onset atrial fibrillation
Participants - exclusion criteria 1. Age <18 years
2. Baseline systolic blood pressure <100 mmHg
3. Known thyroid disease
4. Serum potassium <3.5 mmol/l
5. Pre-treatment with any antiarrhythmic drug
6. Documented permanent AF
7. Atrial flutter and corrected heart rate (QTc) interval >440 msec
8. The duration of tachyarrhythmia estimated by medical history
9. The current guidelines regarding prevention of thromboembolism are also followed
Anticipated start date 24/04/1999
Anticipated end date 30/12/2004
Status of trial Completed
Patient information material
Target number of participants 223
Interventions All patients, a total number of 338 received digoxin and disopyramide and if this restored sinus rhythm within two hours, they were excluded from the study.
Patients were randomized into two groups. One group received intravenous amiodarone
and the other group received oral amiodarone.
Primary outcome measure(s) Restoration of sinus rhythm
Secondary outcome measure(s) Blood pressure monitoring
Sources of funding Greek National Health Service
Trial website
Publications 2007 results on http://www.ncbi.nlm.nih.gov/pubmed/17434635
Contact name Dr  Theodoros  Xanthos
  Address 15B Agiou Thoma street
  City/town Athens
  Zip/Postcode 11527
  Country Greece
  Tel +30 (0)2107462550
  Email theodorosxanthos@yahoo.com
Sponsor Greek National Health Service (Greece)
  Address 15B Agiou Thoma street
  City/town Athens
  Zip/Postcode 11527
  Country Greece
  Tel +30 (0) 2107462501
  Email dperrea@med.uoa.gr
Date applied 05/02/2006
Last edited 18/02/2008
Date ISRCTN assigned 07/03/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central